$BLLN

Atay Oguzhan sold $1.7M of BLLN (indirect holdings)

Atay Oguzhan (Chairman and CEO) sold 12,500 indirectly-held shares of BillionToOne, Inc. (BLLN) at $137.37 ($1.72M total) across 2 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Atay Oguzhan
Published Aug 6, 2026, 12:52 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
medium confidence
Mentioned
$BLLN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest fact is the reported open-market sale by the CEO/Chairman, including trade date, price, and post-transaction holdings, under a pre-arranged 10b5-1 plan.

02

Market read

This provides a fresh, primary-source datapoint on insider activity, but it is not a fundamental catalyst like earnings, guidance, or a deal.

03

What to watch

Traders may overreact to insider sales; the key differentiator here is the pre-arranged nature of the trades, which often reduces informational content.

Relevance 5/10Novelty 4/10Timing: filed 2026-08-05 for a sale executed 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for BillionToOne, Inc. (BLLN).

Company-level read

Ticker impact

$BLLNNeutralMedium confidence
Context

BillionToOne (BLLN) disclosed a Form 4 showing CEO/Chairman Atay Oguzhan sold 12,500 shares at $137.37 on a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven and should fade unless accompanied by other news.

Evidence & confidence

The filing is a primary-source Form 4 and includes transaction size and pricing, but it explicitly states a pre-arranged 10b5-1 plan, reducing interpretive weight versus unscheduled sales.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may reflect routine liquidity planning rather than bearish expectations.

Key entities

  • BillionToOne, Inc.

    Company subject of the Form 4 insider transaction disclosure.

  • Atay Oguzhan

    Chairman and CEO who executed the reported open-market sale under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.